170 related articles for article (PubMed ID: 31379492)
1. A Candidate Regulatory Variant at the
Tian ML; Ni XN; Li JQ; Tan CC; Cao XP; Tan L;
Front Neurosci; 2019; 13():742. PubMed ID: 31379492
[No Abstract] [Full Text] [Related]
2.
Song YN; Li JQ; Tan CC; Wang HF; Tan MS; Cao XP; Yu JT; Tan L;
Front Neurosci; 2019; 13():455. PubMed ID: 31156362
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease.
Zhang H; Ng KP; Therriault J; Kang MS; Pascoal TA; Rosa-Neto P; Gauthier S;
Transl Neurodegener; 2018; 7():23. PubMed ID: 30311914
[TBL] [Abstract][Full Text] [Related]
4. Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology.
Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Schlepckow K; Araque Caballero MÁ; Franzmeier N; Capell A; Fellerer K; Nuscher B; Eren E; Levin J; Deming Y; Piccio L; Karch CM; Cruchaga C; Shaw LM; Trojanowski JQ; Weiner M; Ewers M; Haass C;
Mol Neurodegener; 2019 Jan; 14(1):1. PubMed ID: 30630532
[TBL] [Abstract][Full Text] [Related]
5. The Trajectory of Cerebrospinal Fluid Growth-Associated Protein 43 in the Alzheimer's Disease Continuum: A Longitudinal Study.
Zhang H; Lyu D; Jia J;
J Alzheimers Dis; 2022; 85(4):1441-1452. PubMed ID: 34958042
[TBL] [Abstract][Full Text] [Related]
6. Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical Outcomes.
Pillai JA; Khrestian M; Bena J; Leverenz JB; Bekris LM
Front Aging Neurosci; 2021; 13():676744. PubMed ID: 34276339
[TBL] [Abstract][Full Text] [Related]
7. Disease trajectories in elders with suspected non-Alzheimer's pathophysiology and its comparison with Alzheimer's disease pathophysiology: a longitudinal study.
Li JQ; Song JH; Suckling J; Wang YJ; Zuo CT; Zhang C; Gao J; Song YQ; Xie AM; Tan L; Yu JT
Res Sq; 2023 Mar; ():. PubMed ID: 37034751
[TBL] [Abstract][Full Text] [Related]
8. Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative.
Zettergren A; Lord J; Ashton NJ; Benedet AL; Karikari TK; Lantero Rodriguez J; ; Snellman A; Suárez-Calvet M; Proitsi P; Zetterberg H; Blennow K
Alzheimers Res Ther; 2021 Jan; 13(1):17. PubMed ID: 33419453
[TBL] [Abstract][Full Text] [Related]
9. The Associations of Cerebrospinal Fluid ApoE and Biomarkers of Alzheimer's Disease: Exploring Interactions With Sex.
Liu Y; Song JH; Xu W; Hou XH; Li JQ; Yu JT; Tan L; Chi S;
Front Neurosci; 2021; 15():633576. PubMed ID: 33746700
[TBL] [Abstract][Full Text] [Related]
10. Self-reported obstructive sleep apnea, amyloid and tau burden, and Alzheimer's disease time-dependent progression.
Bubu OM; Umasabor-Bubu OQ; Turner AD; Parekh A; Mullins AE; Kam K; Birckbichler MK; Mukhtar F; Mbah AK; Williams NJ; Rapoport DM; de Leon M; Jean-Louis G; Ayappa I; Varga AW; Osorio RS;
Alzheimers Dement; 2020 Oct; ():. PubMed ID: 33090679
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI.
Toledo JB; Xie SX; Trojanowski JQ; Shaw LM
Acta Neuropathol; 2013 Nov; 126(5):659-70. PubMed ID: 23812320
[TBL] [Abstract][Full Text] [Related]
12. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study.
Morenas-Rodríguez E; Li Y; Nuscher B; Franzmeier N; Xiong C; Suárez-Calvet M; Fagan AM; Schultz S; Gordon BA; Benzinger TLS; Hassenstab J; McDade E; Feederle R; Karch CM; Schlepckow K; Morris JC; Kleinberger G; Nellgard B; Vöglein J; Blennow K; Zetterberg H; Ewers M; Jucker M; Levin J; Bateman RJ; Haass C;
Lancet Neurol; 2022 Apr; 21(4):329-341. PubMed ID: 35305339
[TBL] [Abstract][Full Text] [Related]
13. P-tau and neurodegeneration mediate the effect of β-amyloid on cognition in non-demented elders.
Ma LZ; Hu H; Wang ZT; Ou YN; Dong Q; Tan L; Yu JT
Alzheimers Res Ther; 2021 Dec; 13(1):200. PubMed ID: 34911582
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-β and tau pathology in Alzheimer's disease.
Wang ZB; Ma YH; Sun Y; Tan L; Wang HF; Yu JT;
J Neuroinflammation; 2022 Dec; 19(1):316. PubMed ID: 36578067
[TBL] [Abstract][Full Text] [Related]
15. Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
Ma YH; Wang YY; Tan L; Xu W; Shen XN; Wang HF; Hou XH; Cao XP; Bi YL; Dong Q; Yang JL; Yu JT
J Alzheimers Dis; 2021; 81(1):263-272. PubMed ID: 33749650
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease susceptibility locus in CD2AP is associated with increased cerebrospinal fluid tau levels in mild cognitive impairment.
Xue YY; Chen YH; Lin RR; Huang HF; Wu ZY; Tao QQ;
Neurosci Lett; 2022 Feb; 771():136419. PubMed ID: 34958910
[TBL] [Abstract][Full Text] [Related]
17. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
[TBL] [Abstract][Full Text] [Related]
18. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
19. β-Amyloid-Dependent and -Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease.
Kumar A; Janelidze S; Stomrud E; Palmqvist S; Hansson O; Mattsson-Carlgren N;
Neurology; 2022 Aug; 99(5):e476-e487. PubMed ID: 35641311
[TBL] [Abstract][Full Text] [Related]
20. A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression.
Carrasquillo MM; Allen M; Burgess JD; Wang X; Strickland SL; Aryal S; Siuda J; Kachadoorian ML; Medway C; Younkin CS; Nair A; Wang C; Chanana P; Serie D; Nguyen T; Lincoln S; Malphrus KG; Morgan K; Golde TE; Price ND; White CC; De Jager PL; Bennett DA; Asmann YW; Crook JE; Petersen RC; Graff-Radford NR; Dickson DW; Younkin SG; Ertekin-Taner N
Alzheimers Dement; 2017 Jun; 13(6):663-673. PubMed ID: 27939925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
